The maker of the weight loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of the blockbuster ...

Novo Nordisk offers Wegovy and Ozempic at $199/month for new self-pay patients, valid for the first two months until March 31, 2026. The promotion aligns with a national agreement to improve access ...

Novo Nordisk offers Ozempic Wegovy sold 199 per month for new self-paying patients from Nov. 17 to March 31 with discounted initial doses.

NEW YORK, May 21 (Reuters) - Cigna (CI.N), opens new tab will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an add-on to its pharmacy ...

Wegovy and Zepbound, two popular weight loss GLP-1 medications, would remain cost-effective at a higher price, according to an Oct. 29 revised report from the Institute for Clinical and Economic ...

Novo Nordisk, the Danish pharmaceutical company that has long dominated the obesity treatment market, significantly lowered the prices of its products Wegovy and Ozempic, according to a report by ...

Wegovy and Ozempic prices have dropped as Novo Nordisk cuts costs for most versions of the popular weight-loss and diabetes ...

Novo Nordisk eyes a 2026 comeback as it slashes jobs, cuts U.S. semaglutide prices and focuses on expanding the reach of key ...

Novo Nordisk is expanding its reach in the obesity medicines market by making its blockbuster weight loss drug Wegovy available directly to certain patients for more than half off the product’s list ...

Novo Nordisk's weight-loss drug Wegovy is the subject of a limited voluntary recall after regulators warned that certain doses were "inappropriately released ...

GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study ...

WeightWatchers’ CEO said Wednesday the company plans to sell Novo Nordisk’s  much-anticipated Wegovy in pill form if it is ...